GLP-1 Medications and Type 2 Diabetes
GLP-1 medications were developed for type 2 diabetes and remain a primary treatment. Here's how they work for diabetes, what's safe, and what to discuss with your provider.
Articles · Weight loss · Updated May 8, 2026
The short answer
Yes — GLP-1 medications were originally developed for type 2 diabetes and remain a primary treatment for blood sugar control. Many people with type 2 diabetes take them specifically because they help both with blood sugar and with weight loss. The two effects work together.
That said, if you have diabetes, your treatment requires more careful coordination than weight-loss-only use. Other medications, blood sugar monitoring, and overall health management all factor in.
How GLP-1 helps with type 2 diabetes
GLP-1 medications were FDA-approved for diabetes years before they were approved for weight loss. They support blood sugar control through several mechanisms:
They trigger insulin release when blood sugar is high. GLP-1 medications signal your pancreas to produce more insulin in response to meals. The key: they only do this when blood sugar is elevated, which means they don't typically cause dangerous low blood sugar (hypoglycemia) on their own.
They reduce glucagon. Glucagon is a hormone that raises blood sugar by telling your liver to release glucose. GLP-1 medications reduce glucagon, which means your blood sugar stays lower between meals.
They slow gastric emptying. Food enters your bloodstream more gradually, so blood sugar rises more slowly and steadily after meals.
They improve insulin sensitivity. Over time, GLP-1 medications appear to help your body respond more efficiently to insulin.
The combined effect: lower A1c, fewer blood sugar spikes, and steadier energy throughout the day.
What clinical trials show for diabetes
Both semaglutide and tirzepatide have substantial clinical evidence for type 2 diabetes:
Semaglutide in the SUSTAIN trials reduced A1c by approximately 1.0-1.8 percentage points compared to placebo, depending on dose.
Tirzepatide in the SURPASS trials reduced A1c by approximately 1.7-2.4 percentage points. At higher doses, tirzepatide has shown stronger A1c reduction than semaglutide head-to-head.
For many people with type 2 diabetes, GLP-1 medications can move A1c into a much healthier range — sometimes below the diagnostic threshold for diabetes.
Weight loss and diabetes go together
One of the most important things about GLP-1 for diabetes: the weight loss effect helps the diabetes itself.
Excess body weight is one of the biggest drivers of type 2 diabetes. Even modest weight loss (5-10%) can significantly improve insulin sensitivity, reduce A1c, and in some cases lead to diabetes remission.
This means GLP-1 medications work on diabetes from two directions at once: directly (through the mechanisms above) and indirectly (by helping you lose weight, which improves how your body uses insulin).
Safety considerations if you have type 2 diabetes
GLP-1 is generally considered safe for people with type 2 diabetes — it was developed for this population. But there are specific things to know:
Low blood sugar risk depends on other medications. GLP-1 alone rarely causes hypoglycemia. But if you're also taking insulin or a sulfonylurea (like glipizide or glyburide), your risk of low blood sugar goes up. Your provider may reduce those medications when starting GLP-1.
Monitor blood sugar more closely at first. Especially in the first few weeks as your dose changes, check blood sugar regularly. Patterns may shift quickly.
Watch for signs of pancreatitis. Rare but serious. Severe abdominal pain that radiates to the back, with or without nausea and vomiting, warrants immediate medical attention.
History of medullary thyroid cancer or MEN2: GLP-1 medications are contraindicated for people with personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2.
Diabetic retinopathy: Rapid improvements in blood sugar can temporarily worsen retinopathy in some people. If you have known retinopathy, your eye doctor should be in the loop.
How GLP-1 works alongside other diabetes medications
GLP-1 medications are often added to existing diabetes treatment rather than replacing it. Common combinations:
Metformin + GLP-1: Very common. Metformin and GLP-1 work through different mechanisms and combine well. Most people stay on metformin when starting GLP-1.
Insulin + GLP-1: Often used together. Adding GLP-1 may let you reduce insulin doses. Your provider will adjust insulin carefully to avoid hypoglycemia.
SGLT2 inhibitors + GLP-1: Increasingly used together. Different mechanisms, complementary effects on cardiovascular and kidney health.
Sulfonylureas + GLP-1: Possible but requires careful monitoring. Most providers reduce sulfonylurea doses when adding GLP-1 to lower hypoglycemia risk.
Tirzepatide or semaglutide for diabetes?
Both work for type 2 diabetes. Tirzepatide has shown stronger A1c reduction in head-to-head trials, but semaglutide has a longer track record. The choice often comes down to:
• How much A1c reduction you need
• How much weight loss is also a goal
• Side effect tolerance
• Cost and insurance coverage
• Your other medications
Both medications are covered in detail in tirzepatide vs semaglutide: how to choose.
What to discuss with your provider
If you have type 2 diabetes and are considering GLP-1, talk through:
Your current A1c and blood sugar patterns. Baseline data matters for picking the right starting dose and tracking response.
All your current medications. Especially insulin, sulfonylureas, and any other diabetes drugs. Doses may need adjustment.
Your full medical history. Including thyroid conditions, pancreatitis history, gallbladder issues, and any family history of MEN2 or medullary thyroid cancer.
How you'll monitor blood sugar. Especially in the first weeks, more frequent monitoring is worth it.
Your weight loss goals. If weight loss is also a goal, your provider can factor that into medication selection and dosing.
Common questions
Will GLP-1 cure my diabetes?
GLP-1 doesn't "cure" type 2 diabetes, but it can move some people into remission — meaning blood sugar returns to normal range without medication. This typically requires sustained weight loss and lifestyle changes alongside the medication. Stopping the medication usually means symptoms return.
Can people without diabetes take GLP-1?
Yes. Wegovy and Zepbound are approved specifically for weight management in people without diabetes. The medication works similarly — just without the diabetes label.
Will GLP-1 cause low blood sugar?
On its own, rarely. Combined with insulin or sulfonylureas, the risk increases. Your provider will adjust other medications to minimize this risk.
Do I have to stop my other diabetes medications?
Usually no — GLP-1 is typically added to existing treatment. Your provider may adjust other medication doses based on how you respond.
How quickly will my A1c improve?
Many people see meaningful A1c improvement within 8-12 weeks of starting GLP-1, with continued improvement as the dose increases.
Is compounded GLP-1 safe for diabetes?
Compounded versions use the same active ingredients as brand-name medications. When prescribed by a licensed provider with appropriate monitoring, they can be used for diabetes management. Your provider will determine fit.
How to start
If you have type 2 diabetes and are considering GLP-1 for weight loss, blood sugar management, or both, the first step is a comprehensive provider consultation.
Belle's licensed providers prescribe compounded semaglutide and compounded tirzepatide, and will review your full medical history including diabetes management before prescribing. Complete your medical intake form to get started.
All Belle programs require a licensed provider consultation and prescription. Compounded medications are not FDA-approved finished drug products. This content is for informational purposes and does not constitute medical advice.
Education only, not medical advice.
